BP000094-CYT-137: Recombinant Human 4-1BB Receptor, His Tag
Source: E. coli-derived.
Purity: > 90% as determined by SDS-PAGE.BP000094-CYT-463: Recombinant Human 4-1BB Receptor
Source: E. coli-derived.
The activity was determined by the inhibition of 4-1BB ligand mediated stimulation of IL-8 production by human PBMC. Results: 90% inhibition using 1 for both 4-1BB ligand and 4-1BB receptor.
Purity > 98%, by SDS-PAGE and RP-HPLC.APIM050369: A-1155463
CAS No.: 1235034-55-5.
Purity: >99.5% by HPLC at 214 and 254 nm.
QC: HPLC-MS, NMR, and Quantitative Elemental Analysis.
Solubility: Soluble in DMSO.APIM050276: A-1210477
CAS No.: 1668553-26-1.
Purity: >99% (HPLC at 214 and 254 nm).
QC: HPLC-MS, 1HNMR, and Quantitative Elemental Analysis.
Solubility: Soluble in DMSO.APIM050002: A-1331852
CAS No.: 1430844-80-6
Molecular Formula: C38H38N6O3S.
Molecular Weight: 658.8 (or refer to the Certificate of Analysis, batch-specific).
Purity: >99.5% by HPLC at 214 and 254 nm.
QC: HPLC-MS, NMR, and Quantitative Elemental Analysis.
Solubility: DMSO.APIM050004: ABT-199 (VENETOCLAX)
Purity: 99.9% by HPLC at 214 and 254 nm.
QC: HPLC-MS, 1HNMR, and Quantitative Elemental Analysis Report.
Solubility: DMSO.APIM050004: ABT-199 (VENETOCLAX)
Purity: 99.9% by HPLC at 214 and 254 nm.
QC: HPLC-MS, 1HNMR, and Quantitative Elemental Analysis Report.
Solubility: DMSO.APIM050278: ABT-199 (VENETOCLAX)
CAS No.: 1257044-40-8.
Purity: 99.9% (HPLC at 214 and 254 nm).
QC: HPLC-MS, 1HNMR, and Quantitative Elemental Analysis Report.
Solubility: Soluble in DMSO.BP001345-CE44: Recombinant Human ADP-ribosylarginine hydrolase (ADPRH) Enzyme
Source: E. coli-derived.
Purity: > 95% by reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).